Form 4 for FDMT 4D Molecular Therapeutics, Inc.
Accepted 2023-04-25 00:00:00 ET · period of report 2023-04-21 · accession 0001140361-23-020315 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2023-04-25 | 2023-04-21 | FDMT | Chacko Jacob | Dir | M - OptEx | $9.41 | +5,000 | 5,000 | New | +$47.0K |
| DT | 2023-04-25 | 2023-04-21 | FDMT | Chacko Jacob | Dir | S - Sale+OE | $20.05 | -5,000 | 0 | -100% | -$100.2K |
| DT | 2023-04-25 | 2023-04-21 | FDMT | Chacko Jacob | Dir | M - OptEx | $0.00 | -5,000 | 32.5K | -13% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-21 | M | A | 5,000 | $9.41 | 5,000 | D | — | — | |
| 2 | Common | Common Stock | 2023-04-21 | S | D | 5,000 | $20.05 | 0 | D | — | — | (F2) The transaction was executed in multiple trades in prices ranging from $20.00 to $20.23, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 3 | Derivative | Stock Option (Right to Buy) | 2023-04-21 | M | D | 5,000 | $0.00 | 32,500 | D | $9.41 · — to 2029-03-19 | 5,000 Common Stock | (F3) The stock option is fully vested and exercisable. |